← Leaderboards
Andres J Klein-Szanto
Fox Chase Cancer Center
$7,080,299
Attributed
$7,080,299
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $678.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,080,299 · 9
By mechanism
R01$5,620,570 · 4
P30$827,865 · 3
P50$368,318 · 1
S10$263,546 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProtocols DocumentationBasePlayEnzymesMolecularBiomedical FacilityHistopathologyCancer Registry /ResourceCancer BiologyAnimal ModelCellsTissuesCancer PreventionParaffin EmbeddingCancer CenterPathologistImage AnalysisHistopathology FacilityImmunohistochemistryAutoradiographyBiologicalEquipmentFox Chase Cancer Center
Grant awards (38)
Shared Resource: Histopathology Facility$14,905
P30 · FY2021 · CA · contact PI
Shared Resource: Histopathology Facility$87,172
P30 · FY2020 · CA · contact PI
Shared Resource: Histopathology Facility$8,696
P30 · FY2020 · CA · contact PI
Shared Resource: Histopathology Facility$81,556
P30 · FY2019 · CA · contact PI
Shared Resource: Histopathology Facility$76,511
P30 · FY2018 · CA · contact PI
Shared Resource: Histopathology Facility$10,869
P30 · FY2018 · CA · contact PI
Shared Resource: Histopathology Facility$5,967
P30 · FY2018 · CA · contact PI
Shared Resource: Histopathology Facility$76,509
P30 · FY2017 · CA · contact PI
Shared Resource: Histopathology Facility$73,244
P30 · FY2016 · CA · contact PI
Furin and the Etiopathogenesis of UV-Induced Skin Cancer$358,605
R01 · FY2012 · CA · contact PI
Furin and the Etiopathogenesis of UV-Induced Skin Cancer$351,225
R01 · FY2011 · CA · contact PI
Furin and the Etiopathogenesis of UV-Induced Skin Cancer$362,088
R01 · FY2010 · CA · contact PI
Furin and the Etiopathogenesis of UV-Induced Skin Cancer$361,569
R01 · FY2009 · CA · contact PI
Tissue Arraying, Immunostaining, and Imaging System$263,546
S10 · FY2008 · RR · contact PI
Progression of Chemical Induced Skin Tumors$338,914
R01 · FY2007 · CA · contact PI
The Role of VILIP-1 in Development of Skin Tumors$320,225
R01 · FY2007 · CA · contact PI
Progression of Chemical Induced Skin Tumors$349,036
R01 · FY2006 · CA · contact PI
The Role of VILIP-1 in Development of Skin Tumors$329,789
R01 · FY2006 · CA · contact PI
Progression of Chemical Induced Skin Tumors$358,493
R01 · FY2005 · CA
The Role of VILIP-1 in Development of Skin Tumors$303,953
R01 · FY2005 · CA
Progression of Chemical Induced Skin Tumors$359,550
R01 · FY2004 · CA
Progression of Chemical Induced Skin Tumors$359,550
R01 · FY2003 · CA
PROGRESSION OF CHEMICAL INDUCED SKIN TUMORS$310,175
R01 · FY2002 · CA
CORE--TUMOR BANK$196,218
P30 · FY2002 · CA
Core--Tissue procurement$165,355
P50 · FY2002 · CA
PROGRESSION OF CHEMICAL INDUCED SKIN TUMORS$302,552
R01 · FY2001 · CA
MOLECULAR CHANGES IN ORAL LESIONS OF CHEMICAL ETIOLOGY$279,678
R01 · FY2001 · CA
CORE--TUMOR BANK$196,218
P30 · FY2001 · CA
Core--Tissue procurement$165,355
P50 · FY2001 · CA
CORE--TUMOR BANK$0
P30 · FY2001 · CA
CORE--TUMOR BANK$0
P30 · FY2001 · CA
PROGRESSION OF CHEMICAL INDUCED SKIN TUMORS$301,453
R01 · FY2000 · CA
MOLECULAR CHANGES IN ORAL LESIONS OF CHEMICAL ETIOLOGY$273,715
R01 · FY2000 · CA
Core--Tissue procurement$18,804
P50 · FY2000 · CA
Core--Tissue procurement$18,804
P50 · FY2000 · CA
CORE--TUMOR BANK$0
P30 · FY2000 · CA
CORE--TUMOR BANK$0
P30 · FY2000 · CA
CORE--HISTOPATHOLOGY$0
P30 · FY2000 · CA